目的 分析撫順市中醫(yī)院心病科2016-2018年中藥注射劑的使用情況以及變化趨勢(shì)，為臨床合理用藥提供參考。方法 收集2016-2018年撫順市中醫(yī)院心病科中藥注射劑的使用數(shù)據(jù)，分析銷售金額、用藥頻度（DDDs）、限定日費(fèi)用（DDC）以及藥品排序比（B/A）；采用回顧性分析方法，隨機(jī)抽取本院心病科2016-2018年使用金額排前3位的中藥注射劑各100例，分析其用藥合理性。結(jié)果 中藥注射劑的使用金額占比較高，但呈下降趨勢(shì)。其中丹紅注射液的使用金額穩(wěn)居第1位。注射用血栓通、丹紅注射液、疏血通注射液的DDDs均居前3位，顯示較高的使用率。大株紅景天注射液、丹紅注射液、注射用丹參多酚酸鹽的DDC值偏高，居前3位。大多數(shù)中藥注射劑的B/A接近于1.00。中藥注射劑的使用存在療程不適宜、重復(fù)用藥、溶媒選擇不當(dāng)?shù)惹闆r。結(jié)論 撫順市中醫(yī)院心內(nèi)科中藥注射劑的使用總體上比較合理，但仍存在一些不合理用藥現(xiàn)象，臨床藥師需積極干預(yù)，繼續(xù)開展處方醫(yī)囑點(diǎn)評(píng)、合理用藥宣教等工作，保證臨床用藥合理性。

Objective To analyze the usage and variation tendency of traditional Chinese medicine (TCM) injections of Department of Cardiology in Fushun Hospital of Chinese Medicine from 2016 to 2018, and provide a reference for clinical rational drug use. Methods Consumption sum, defined daily doses (DDDs), defined daily cost (DDC), and drug sequence ratio of TCM injections in Department of Cardiology and from 2016 to 2018 were analyzed statistically. A retrospective analysis method was used to select randomly TCM injections (100 cases) with the top 3 consumption sum in Department of Cardiology from 2016 to 2018, and the rationality of drug use was analyzed. Results The ratio of consumption sum of TCM injections was relatively high, but showing a reducing trend year by year. Consumption sum of Danhong Injection always ranked the first of single products. DDDs of Xueshuangtong Injection, Danhong Injection, and Shuxuetong Injection had always been ranked among the top three, showing high rate of utilization. DDC of Sofren Injection, Danhong Injection, and Salvianates for injection were high, and ranked the top three. The drug sequence ratio of most TCM injections was equal to 1.00. There were indications such as unsuitable course, repeated use of drugs, and improper choice of solvents in the use of TCM injections. Conclusion The use of TCM injections in Department of Cardiology is generally reasonable, but there were still some phenomena of irrational use of drugs. It is necessary to regulate drug use behaviors through clinical pharmacist interventions, prescription medical opinion, and rational drug education, to ensure the rationality of drug use.

R972